Direxion Daily Healthcare Bull 3X SharesCURE
CURE
0
Funds holding %
of 7,431 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
2.27% less ownership
Funds ownership: 8.24% [Q1] → 5.97% (-2.27%) [Q2]
5% less funds holding
Funds holding: 20 [Q1] → 19 (-1) [Q2]
29% less call options, than puts
Call options by funds: $1.26M | Put options by funds: $1.76M
32% less capital invested
Capital invested by funds: $12.7M [Q1] → $8.71M (-$4.04M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for CURE.
Financial journalist opinion
Based on 3 articles about CURE published over the past 30 days
Neutral
ETF Trends
6 days ago
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Positive
ETF Trends
2 weeks ago
CURE: Make an Adventurous Bet on an Undervalued Sector
The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group has lived up to its reputation for being less volatile than the broader market.
Neutral
ETF Trends
3 weeks ago
Top Performing Leveraged/Inverse ETFs: 07/27/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Neutral
Seeking Alpha
2 months ago
CURE: A Useful Speculative Tool But Not An Investing Hold
CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause value decay over time, so holding CURE for months or years leads to underperformance versus the underlying index. CURE is effective for tactical trades or hedges on short-term healthcare sector moves, but not for buy-and-hold strategies.
Positive
ETF Trends
5 months ago
2 Sectors to Trade as Equity Funds See Higher Inflows
Sometimes traders can set up a potential plays when they see where investor money is flowing. This is available with fund inflows, which saw technology and healthcare equities gain a lion's share of February's flows.
Positive
Zacks Investment Research
6 months ago
5 Leveraged ETFs With Double-Digit Gains Halfway Through Q1
We highlight a bunch of the best-performing leveraged equity ETFs halfway through the first quarter.
Positive
ETF Trends
6 months ago
Rising Number of Flu Cases Could Elevate These ETFs
Cases of the flu have reached elevated levels as of late. This could keep healthcare stocks and ETFs with a healthcare focus on the radar for traders.
Positive
Zacks Investment Research
6 months ago
5 Leveraged ETFs That Witnessed Double-Digit Gains in January
We highlight a bunch of the best-performing leveraged equity ETFs of January.
Positive
Seeking Alpha
7 months ago
CURE: Analyst Estimates Point To Significant Gains In 2025
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks. Since October 2024 the forward P/E ratio for CURE's largest holdings has marginally increased. Even so Wall Street analysts predict a weighted average gain of 21% for CURE's top ten components over the next 12 months.
Neutral
ETF Trends
8 months ago
There Could Be Value in Healthcare Stocks Ahead of 2025
When a new presidential administration is set to take office, there's uncertainty as to whether specific sectors could be impacted. In the case of healthcare, that's certainly the case, especially in biotech.
Charts implemented using Lightweight Charts™